๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Therapy of hepatitis C: Interferon alfa-n1 trials

โœ Scribed by G C Farrell

Book ID
111700342
Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
162 KB
Volume
26
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Therapy of hepatitis C: Interferon alfa-
Therapy of hepatitis C: Interferon alfa-2a trials
โœ W M Lee ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 183 KB ๐Ÿ‘ 2 views

Interferon alfa-2a resembles other recombinant alpha inter-2a has recently been approved by the Food and Drug Administration for use as therapy of chronic hepatitis C in a regimen ferons in structure and pharmacology. Studies delineating its efficacy suggest that after 6 to 12 months of therapy, sus

Therapy of hepatitis C: Meta-analysis of
Therapy of hepatitis C: Meta-analysis of interferon alfa-2b trials
โœ R L Carithers Jr; S S Emerson ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 182 KB ๐Ÿ‘ 2 views

We performed an independent meta-analysis of all available blind, placebo-controlled trials confirmed the efficacy of this randomized clinical trials of interferon alfa-2b in patients with agent in normalizing alanine aminotransferase (ALT) values chronic hepatitis C. Articles published between 1986

Therapy of hepatitis C: Consensus interf
Therapy of hepatitis C: Consensus interferon trials
โœ E B Keeffe; F B Hollinger ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 234 KB ๐Ÿ‘ 2 views

Chronic hepatitis C is an insidious disease associated with prior interferon therapy were more likely to have a serum HCV RNA end-of-retreatment and sustained response than significant morbidity and mortality. Currently, the only approved therapies for chronic hepatitis C are the alpha interfer-pati